Background
==========

Infertility remains a major clinical problem that occurs in 10 to 15% of couples worldwide \[[@B1]\], and male factor infertility accounts for 40 to 50% of all infertility cases \[[@B2]\]. Although several causes have been identified for impaired male fertility \[[@B3]\], the aetiology remains unknown in nearly half of all cases. Currently, a large amount of attention is being paid to the potential effects of sperm DNA damage on male infertility \[[@B4]\]. DNA damage in the male germ line appears as a risk factor for adverse clinical outcomes, including poor semen quality, low fertilization rates, impaired pre-implantation development, miscarriage and an increased risk of morbidity in the offspring \[[@B5]-[@B7]\].

Although the clinical significance of testing sperm DNA integrity has been clearly emphasized, the origin of DNA damage in spermatozoa is poorly understood. One mechanism is that deficits in the DNA repair system during spermatogenesis can have negative effects on the integrity of sperm DNA \[[@B8],[@B9]\]. Our previous data have provided strong evidence that some genetic polymorphisms in genes involved in DNA repair were associated with the development of sperm DNA damage and male infertility \[[@B10]-[@B13]\].

Among all DNA repair mechanisms, DNA mismatch repair (MMR) plays a critical role in the maintenance of genetic integrity and malfunctions can lead to various cancers in mammals \[[@B14]-[@B16]\]. Studies of gene knockout mice indicate that several members of the MMR family also participate in the meiotic recombination process and are involved in gametogenesis \[[@B17],[@B18]\]. Three MutL homologues (MLH1, MLH3 and PMS2) and two MutS homologues (MSH4 and MSH5) are involved in this process.

Based on their important physiological functions, these five MMR genes are good candidate genes for explaining male infertility. Recently, analysis of polymorphic markers in candidate genes helped us to understand the etiology and the susceptibility of male infertility \[[@B19]-[@B21]\]. The purpose of this work is three-fold: (1) to examine whether MMR gene polymorphisms are associated with increased risk of azoospermia or oligozoospermia, (2) to ascertain whether genetic variants in MMR genes result in sperm DNA damage and, thereby, increase male infertility, and (3) to investigate the biological activity of the significant functional variants.

Methods
=======

Subjects and sample collection
------------------------------

The study was approved by the Ethics Review Board of the Nanjing Medical University. All the studies involving human subjects were conducted in full compliance with government policies and the Declaration of Helsinki. A total of 1,657 infertile patients, diagnosed with unexplained male factor infertility, were drawn from the Centre of Clinical Reproductive Medicine between April 2005 and March 2009 (NJMU Infertile Study). All participants completed an informed consent and a questionnaire, including detailed information, such as age, cigarette smoking, alcohol drinking, tea and vitamin consumption, and abstinence time. All patients underwent at least two semen analyses, and those with a history of orchitis, obstruction of the vas deferens, chromosomal abnormalities, or micro-deletions of the azoospermia factor region on the Y chromosome were excluded \[[@B22]\]. In the final analysis, 1,292 idiopathic infertility patients aged 24 to 42 years old were included, and were divided into three subgroups: 268 infertility patients with non-obstructive azoospermia, 256 infertility patients with oligozoospermia (sperm counts \< 20 × 10^6^/ml) and 768 infertility patients with normal count (sperm counts ≥ 20 × 10^6^/ml).

The control group included 480 fertile men ranging from 25 to 40 years of age who had fathered at least one child without assisted reproductive technologies and had normal semen parameters. The semen analysis for sperm concentration, motility and morphology was performed following the World Health Organization criteria \[[@B23]\].

SNP selection and genotyping
----------------------------

We selected the tagging SNPs by using genotype data obtained from unrelated Han Chinese individuals from Beijing in the HapMap project (HapMap Data Rel 24/Phase II Nov08, on NCBI B36 assembly, dbSNP b126). To examine the gene extensively, we searched the MMR genes, including 2,000 bp of the flanking regions both upstream and downstream of the gene, using the pairwise option of the Haploview 4.0 software (Mark Daly\'s Lab, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA). The tagging SNPs were selected on the basis of pairwise linkage disequilibrium with a r^2^threshold of 0.8 and minor allele frequency ≥ 0.05 to capture all the common SNPs. In total, 19 SNPs were chosen in these 5 genes. In addition, a non-synonymous SNP (rs1799977) in *MLH1*and a non-synonymous SNP (rs2075789) in *MSH5*that cause missense mutations were included.

Genotyping was performed using TaqMan 7900HT Sequence Detection System and GenomeLab SNPstream high-throughput 12-plex genotyping platform (Beckman Coulter, Fullerton, CA, USA). Sequences of forward, reverse and extension primers are listed in Additional file [1](#S1){ref-type="supplementary-material"} (Table S1). For quality control, the genotyping was done without knowledge of case/control status of the subjects, and a random 5% of cases and controls were genotyped twice by different individuals, and the reproducibility was 100%. To confirm the genotyping results, selected PCR-amplified DNA samples (n = 2, for each genotype) were examined by DNA sequencing and the results were also consistent.

DNA fragmentation analysis
--------------------------

After a period of 48 to 72 h of sexual abstinence, semen samples were collected by masturbation into wide-mouthed sterile containers and were delivered to the laboratory within 1 h of ejaculation. The diluted samples were cooled gradually at 5°C for 2 h, frozen at -70°C for Tdt-mediated dUTP nick end labelling (TUNEL) evaluation. A detailed protocol of the TUNEL assay for human sperm has been described previously \[[@B24]\]. TUNEL labeling was carried out using a Cell Death Detection kit (APO-DIRECT kit; BD Biosciences PharMingen, San Diego, CA, USA) according to the manufacturer\'s instructions. Briefly, semen samples were thawed in a 37°C water bath and immediately diluted with buffer (0.15 M NaCl, 0.01 M Tris, 0.001 M EDTA, pH 7.4) to obtain a sperm concentration of 1 to 2 × 10^6^/ml. Washed sperm was resuspended in 2% paraformaldehyde for 30 minutes at room temperature. After rinsing in PBS, samples were resuspended in permeabilization solution (0.2% Triton X-100, 0.1% sodium citrate) for 10 minutes on wet ice. TUNEL reagent (50 μl) was added to each sample. For each batch, a negative control lacking the terminal deoxynucleotidyl transferase and a positive control treated with DNase I were included to ensure assay specificity. After incubation for 1 h at 37°C, samples were analyzed immediately by flow cytometry (FACSCalibur; BD Biosciences Pharmingen, San Diego, CA, USA). Flow during the analysis was controlled at approximately 500 spermatozoa/sec, and 10,000 cells were analyzed for each sample. The percentage of FITC-positive cells (FL1 channel) was calculated as the percentage of cells with a fluorescence intensity exceeding the threshold obtained with the negative control.

Plasmid construction
--------------------

To evaluate the potential effects of *PMS2*rs1059060 (Ser775Asn) polymorphisms on the interaction between MLH1 and PMS2, fluorescence resonance energy transfer (FRET) technology and immunoprecipitation were performed. The cDNA encoding MLH1 or PMS2 was generated by PCR from a human testis cDNA library.

For the FRET assay, the primers used for amplifying PMS2 (amino acids 655-856) were 5\'-CGTT[AAGCTT]{.ul}GGAGAAAATCAAGCAGCCGAAG-3\'/5\'**-**ATAC[GGATCC]{.ul}CAGGTTGGCGATGTGTCTCAT -3\', including *HindIII*and *BamHI*restriction sites (underlined sequences). Point mutations for PMS2 were performed using QuikChange Site-Directed Mutagenesis Kit (Stratagene, La. Jolla, CA, USA). The amplified fragment of PMS2 and its genetic variants were cloned into the pEYFP-C1 vector (Clonetech, Palo Alto, CA, USA). Similarly, the cDNA sequence encoding MLH1 (amino acids 506-756) was amplified by PCR using the following primers: 5\'-CGTT[GAATTC]{.ul}GTGTTTTGAGTCTCCAGGAAGAAA-3\'/5\'-ATAC[GGATCC]{.ul}ACACCTCTCAAAGACTTTGTAT-3\', which contain *EcoRI*and *BamHI*restriction sites (underlined sequences). This amplified fragment was ligated into pECYP-C1 vector (Clonetech, USA). For immunoprecipitation, the cloning of the full-length PMS2 and MLH1 cDNA constructs into pcDNA3.1 (Invitrogen, Carlsbad, CA, USA), between *NheI*and *BamHI*, has already been described \[[@B25]\]. The integrity of the inserts was confirmed by sequence analysis.

Cell culture and transfection
-----------------------------

MutLα-deficient HEK293T cells were cultured in DMEM: F12 (1:1) (Gibco, Carlsbad, CA, USA), supplemented with 10% foetal bovine serum and 0.1% streptomycin/penicillin (Gibco, USA) in a humidified atmosphere with 5% CO~2~at 37°C. Cells were seeded onto 30 mm dishes with poly-L-lysine-coated glass coverslips and co-transfected with YFP recombinant plasmid (YFP-PMS2 or variants of YFP-PMS2) and CFP recombinant plasmid (CFP-MLH1) using Lipofectamine 2000 (Invitrogen) until the cells were at 50 to 60% confluence, according to the manufacturer\'s protocols. The transfection efficiency was compared by Western blotting at 72 hours after transfection using anti-PMS2 (A16-4) (1:100; BD Biosciences), anti-MLH1 (G168-728) (1:100; BD Biosciences), and anti-β actin (1:5000; Santa Cruz Biotechnology, CA, USA) antibodies.

Image analysis and calculation of fluorescence resonance energy transfer ratios
-------------------------------------------------------------------------------

We used a Zeiss LSM710 confocal microscope (Carl Zeiss, Jena, Germany) operating with a 40 mW argon laser. Filter-cube specifications for the fluorescent channels were as follows for excitation and emission, respectively: enhanced cyan fluorescent protein (ECFP), 430 ± 25 and 470 ± 30 nm; enhanced yellow fluorescent protein (EYFP), 500 ± 20 and 535 ± 30 nm; and fluorescence resonance energy transfer (FRET), 430 ± 25 and 535 ± 30 nm.

Image analysis involved three basic operations: subtraction of background autofluorescence and blurred light, quantification of fluorescence intensity, and calculation of a corrected FRET (FRETc) by the following equation:

*FRETc = (I~DA~- a I~AA~- d I~DD~)/I~AA~*, where *I~DA~*is the fluorescence intensity from the FRET filter set and *I~DD~*and *I~AA~*are the fluorescent intensities from ECFP (the donor) and EYFP (the acceptor), respectively. The cross-talk coefficients *a*and *d*were considered constant. The corrected FRET ratio was defined as FRETc/I~DD~.

Co-Immunoprecipitation and Western blotting
-------------------------------------------

Proteins were extracted from co-transfected HEK293T cells by the M-PER^®^Mammalian Protein Extraction Reagent (Pierce Bio, Thermo, Rockford, IL, USA) according to the manufacturer\'s instruction. Approximately 200 μg total cell protein was transferred to a 1.5 ml microcentrifuge tube, and 20 μl of Protein A/G PLUS-Agarose (Santa Cruz Biotechnology, CA, USA) was added to the supernatant and the mixture was incubated at 4°C on a rocker platform for one hour. After this incubation, 2 μg anti-MLH1 N-20 (Santa Cruz Biotechnology, CA, USA) was added and incubated with shaking at 4°C overnight. The immunoprecipitates were collected by centrifugation at 1,000 × g for 5 minutes at 4°C, washed 4 times with lysis buffer and then the precipitates were collected for the Western blotting detection with the anti-PMS2 (A16-4) (1:100; BD Biosciences) antibody. Proteins were then detected with a Phototope-HRP Western Blot Detection kit (Cell Signalling Technology, Inc., Beverly, MA, USA).

Statistical analyses
--------------------

Differences in select demographic variables, as well as smoking and alcohol status, between the cases and the controls, were evaluated using the χ^2^test. The Student\'s *t*test was used to evaluate continuous variables, including age and pack-years of cigarette smoking. The Hardy-Weinberg equilibrium was tested using a goodness-of-fit χ^2^test. We used unconditional multivariate logistic regression analysis to examine associations between genetic polymorphisms and male infertility risk by estimating ORs and 95% confidence intervals (95% CI). To reduce the potential for spurious findings due to multiple testing, we applied the False Discovery Rate (FDR) method to the *P-*values for the differences of genotype distributions among cases and controls. False Discovery Rate (FDR) is a new approach to the multiple comparisons problem. Instead of controlling the chance of any false positives (as Bonferroni methods do), FDR controls the expected proportion of false positives among suprathreshold voxels \[[@B26]\].

Sperm DNA fragmentation was normalized by natural logarithm (ln) transformation. Linear regression models were used to estimate the association with ln-transformed sperm fragmentation values for each SNP independently. Models were adjusted for age, smoking status, drinking status and abstinence time. All *P-*values presented are two-sided and all analyses were carried by the Statistical Analysis Software, version 9.1.3 (SAS Institute, Cary, NC, USA).

Results
=======

Subject characteristics
-----------------------

The final study population consisted of 1,772 Han Chinese individuals, composed of 480 fertile controls, 268 infertility patients with non-obstructive azoospermia, 256 infertility patients with oligozoospermia (sperm counts \< 20 × 10^6^/ml) and 768 infertility patients with normal sperm count (sperm counts ≥ 20 × 10^6^/ml). The frequency distributions of selected characteristics of the case patients and control subjects are presented in Table [1](#T1){ref-type="table"}. No significant differences were observed between cases and controls with regard to drinking status or age. However, there was a significantly higher percentage of smokers among cases than controls (*P*\< 0.001). Among smokers, cases also reported greater cigarette consumption than controls, as assessed by the mean number of pack-years (*P*\< 0.05). As expected, semen parameters, such as sperm concentration and sperm motility, were significantly higher in fertile controls than infertile cases (*P*\< 0.001).

###### 

Distribution of selected characteristics between cases and fertile controls

  -----------------------------------------------------------------------------------------------------------------
  Variables                       Controls\      **Case 1**^**a**^\   **Case 2**^**b**^\                 
                                  (n = 480)      (n = 524)            (n = 768)                          
  ------------------------------- -------------- -------------------- -------------------- ------------- ----------
  Age (mean ± SEM)                28.1 ± 0.16    28.3 ± 0.16          0.374                28.3 ± 0.14   0.355

  Smoking stauts                                                                                         

  Never                           278 (57.9)     238 (45.4)           \< 0.001             363 (47.3)    \< 0.001

  Ever                            202 (42.1)     286 (54.6)                                405 (52.7)    

  Pack-years (mean ± SEM)^c^      4.3 ± 0.21     5.2 ± 0.20           0.002                4.9 ± 0.14    0.014

  Drinking status                                                                                        

  Never                           425 (88.5)     447 (85.3)           0.129                667 (86.8)    0.377

  Ever                            55 (11.5)      77 (14.7)                                 101 (13.2)    

  Semen parameters (mean ± SEM)                                                                          

  Concentration (× 10^6^/ml)      102.6 ± 3.07   5.12 ± 0.38          \< 0.001             73.6 ± 2.12   \< 0.001

  Motility (%)                    65.3 ± 0.58    3.26 ± 0.27          \< 0.001             37.9 ± 0.55   \< 0.001

  Volume (ml)                     2.80 ± 0.07    2.37 ± 0.07          \< 0.001             2.78 ± 0.05   0.818

  Sperm DNA fragmentation (%)     n\. d.         n\. d.                                    19.5 ± 0.82   
  -----------------------------------------------------------------------------------------------------------------

^a^Case 1: idiopathic infertile men with azoospermia or oligozoospermia.

^b^Case 2: idiopathic infertile men with normal sperm count.

^c^Among ever smokers.

^d^*P-*values were derived from the χ^2^test for categorical variables (smoking and drinking status) and t test for continuous variables (age and pack-years).

n\. d.: not detected.

Allelic frequencies and genotype distributions of MMR polymorphisms
-------------------------------------------------------------------

The position and minor allele frequency among Chinese of the 21 SNPs in the HapMap database are presented in Additional file [2](#S2){ref-type="supplementary-material"} (Table S2). All SNPs were in Hardy-Weinberg equilibrium among the controls, except for rs3117572 (*P*= 0.024). Inspection of the cluster plots indicated good discrimination between genotypes, suggesting that these deviations from HWE are likely to be chance observations. The genotype distributions among cases and controls are presented in Table [2](#T2){ref-type="table"}. Overall, the genotype frequencies of three SNPs were significantly different between the patients with azoospermia or oligozoospermia and the controls (*P*= 0.032 for rs4647269, *P*= 0.003 for rs1059060 and *P*= 0.002 for rs2075789). Moreover, the genotype frequencies of rs1059060 were also significantly different between the patients with normal sperm count and the controls (*P*= 2.0 × 10^-4^).

###### 

Distribution of the genotype in selected SNPs of MMR genes

  ----------------------------------------------------------------------------------------------------------------------
  Gene     tSNP         Controls MAF   **Case1**^**a**^**MAF**   ***P***^**c**^   **Case2**^**b**^\   ***P***^**c**^
                                                                                  MAF                 
  -------- ------------ -------------- ------------------------- ---------------- ------------------- ------------------
  *MLH1*                                                                                              

           rs1799977    0.023          0.028                     0.628            0.025               0.828

           rs4647269    0.047          0.075                     **0.032**        0.067               0.175

           rs1540354    0.304          0.343                     0.326            0.331               0.428

  *PMS2*                                                                                              

           rs3815383    0.332          0.332                     0.923            0.342               0.816

           rs2286680    0.074          0.080                     0.772            0.089               0.491

           rs11769380   0.410          0.419                     0.816            0.379               0.736

           rs1059060    0.091          0.146                     **0.003**        0.170               **2.0 × 10^-4^**

           rs2228006    0.063          0.054                     0.520            0.056               0.582

  *MLH3*                                                                                              

           rs13712      0.184          0.185                     0.913            0.185               0.962

           rs7156586    0.222          0.217                     0.832            0.406               0.527

           rs175049     0.185          0.173                     0.646            0.177               0.727

  *MSH4*                                                                                              

           rs1021462    0.309          0.336                     0.592            0.317               0.842

  *MSH5*                                                                                              

           rs3749953    0.121          0.154                     0.278            0.148               0.653

           rs1150793    0.142          0.141                     0.960            0.138               0.827

           rs707939     0.359          0.337                     0.582            0.357               0.886

           rs707938     0.304          0.331                     0.557            0.336               0.231

           rs3115672    0.375          0.402                     0.681            0.377               0.929

           rs3117572    0.223          0.206                     0.724            0.231               0.782

           rs2299850    0.063          0.056                     0.652            0.068               0.720

           rs9461718    0.144          0.161                     0.472            0.157               0.567

           rs2075789    0.081          0.139                     **0.002**        0.097               0.485
  ----------------------------------------------------------------------------------------------------------------------

Abbreviations: MAF, minor allele frequency.

^a^Case 1: idiopathic infertile men with azoospermia or oligozoospermia.

^b^Case 2: idiopathic infertile men with normal sperm count.

Data in bold highlights the statistic significant results.

^c^False Discovery Rate (FDR) corrected *P*-value.

Data in *boldface*represent *P*\< 0.05.

Logistic regression analyses showed that in the dominant-effect model, significantly increased risks of azoospermia or oligozoospermia were associated with rs4647269 CT/TT (adjusted OR = 1.63, 95% CI: 1.10 to 2.41), rs1059060 GA/AA (adjusted OR = 1.60, 95% CI: 1.17 to 2.18) and rs2075789GA/AA (adjusted OR = 1.83, 95% CI: 1.32 to 2.55), as compared to wild-type homozygous carriers (Table [3](#T3){ref-type="table"}). Meanwhile, a significantly increased risk of male infertility with normal sperm count was associated with the rs1059060 GA/AA genotypes (adjusted OR = 1.83, 95% CI: 1.37 to 2.43), as compared to wild-type homozygotes.

###### 

Genotype frequencies of the four SNPs in MMR genes in patients and controls and their associations with male infertility risk

  SNP ID       Genotype   Controls (n = 480)   **Case 1**^**a**^**(n = 524)**   Case 2^b^(n = 768)                  
  ------------ ---------- -------------------- -------------------------------- ---------------------- ------------ ----------------------
  *MLH1*                                                                                                            
  rs4647269    CC         431 (90.5)           444 (85.5)                       Reference              665 (86.6)   Reference
               CT         45 (9.4)             72 (13.9)                        1.56 (1.05 to 2.32)    94 (12.2)    1.34 (0.92 to 1.96)
               TT         0 (0.0)              3 (0.6)                          NA                     4 (0.5)      NA
               CT/TT      45 (9.4)             75 (14.4)                        1.63 (1.10 to 2.41)    98 (12.7)    1.39 (0.93 to 2.01)
  *P*~trend~                                                                    0.009                               0.044
  *PMS2*                                                                                                            
  rs1059060    GG         393 (82.6)           387 (74.6)                       Reference              534 (69.5)   Reference
               GA         79 (16.6)            112 (21.6)                       1.43 (1.03 to 1.96)    197 (25.6)   1.82 (1.36 to 2.44)
               AA         4 (0.8)              20 (3.8)                         5.03 (1.70 to 14.84)   31 (4.0)     5.65 (1.98 to 16.15)
               GA/AA      83 (17.4)            132 (25.4)                       1.60 (1.17 to 2.18)    228 (29.6)   1.83 (1.37 to 2.43)
  *P*~trend~                                                                    0.0003                              \< 0.0001
  *MSH5*                                                                                                            
  rs2075789    GG         401 (85.7)           392 (76.4)                       Reference              626 (83.2)   Reference
               GA         58 (12.4)            99 (19.3)                        1.73 (1.22 to 2.47)    106 (14.1)   1.16 (0.82 to 1.63)
               AA         9 (1.9)              22 (4.2)                         2.48 (1.13 to 5.46)    20 (2.6)     1.41 (0.63 to 3.12)
               GA/AA      67 (14.3)            121 (23.6)                       1.83 (1.32 to 2.55)    126 (19.7)   1.19 (0.86 to 1.64)
  *P*~trend~                                                                    0.0002                              0.224

^a^Case 1: idiopathic infertile men with azoospermia or oligozoospermia.

^b^Case 2: idiopathic infertile men with normal sperm count.

^c^Adjustment for age, smoking status and alcohol use.

Association between MMR polymorphisms and sperm DNA fragmentation
-----------------------------------------------------------------

Considering the importance of the MMR pathway in maintenance of DNA integrity, we further evaluated the effects of these three SNPs on sperm DNA fragmentation. In the present study, semen samples were pre-treated with cryopreservation prior to TUNEL analyses. However, it has been demonstrated that the process of cryopreservation can lead to an increase in oxidative stress and percentage DNA fragmentation \[[@B27]\]. To determine whether the results of the TUNEL analyses were profoundly influenced by cryopreservation in our study, 10 semen samples were pre-treated with or without cryopreservation prior to TUNEL analyses. As shown in Additional file [3](#S3){ref-type="supplementary-material"} (Table S3), modest but significant elevated levels of sperm DNA fragmentation were induced by cryopreservation (*P*= 0.001). However, all the semen samples undergo the same cryopreservation process, thus we believe that the effect of cryopreservation, if any, is unlikely to be substantial. The non-normal distribution of sperm DNA damage levels and sperm concentration were natural log (ln) transformed for further association studies (skewness-kurtosis tests *P*\> 0.05). After adjustment for age, smoking, alcohol use and length of abstinence, we found that subjects who carried the rs4647269 CT/TT genotypes displayed markedly higher levels of sperm DNA fragmentation compared with the CC homozygotes (mean ± S.D., 11.82% ± 2.66% vs. 26.58% ± 1.97%; *P*\< 0.001) (Figure [1A](#F1){ref-type="fig"}). Moreover, a gradual increase in sperm DNA fragmentation was found among the three *PMS2*rs1059060 subgroups (mean ± S.D., 12.30% ± 2.72%, 17.99% ± 2.27%, and 24.78% ± 1.70% for GG, GA and AA, respectively; *P*~trend~\< 0.001) (Figure [1B](#F1){ref-type="fig"}). However, no significant difference was observed for the *MSH5*rs2075789 (Figure [1C](#F1){ref-type="fig"}).

![**Box-and-whisker plots of sperm DNA fragmentation for different genotypes**. The boxes represent the 25^th^and 75^th^percentiles; whiskers are lines extending from each end of the box covering the extent of the data on 1.5 × inter-quartile range. The median value is denoted as the line that bisects the boxes. Circles and asterisks represent the outlier values. Significant differences were measured by multiple linear regression.](1741-7015-10-49-1){#F1}

Effects of the PMS2 Ser775Asn polymorphism on MLH1 and PMS2 interaction
-----------------------------------------------------------------------

The *PMS2*Ser775Asn polymorphism (rs1059060) was potentially located within the MLH1-PMS2 interacting domain. Therefore, we examined whether *PMS2*Ser775Asn polymorphisms influence binding between MLH1 and PMS2. HEK293T cells were transiently co-transfected with plasmids encoding the MLH1 (amino acids 506-756) and wild-type or genetic variants of PMS2 (amino acids 675-850). The schematic diagram of the FRET assay is summarized in Additional file [4](#S4){ref-type="supplementary-material"} (Figure S1). By confocal fluorescence detection, we found that there was a weak interaction between MLH1 and PMS2-775Asn proteins, for little FRETc was detected in cells co-expressing CFP-MLH1 and YFP-PMS2-775Asn plasmid (Figure [2B](#F2){ref-type="fig"}). Cells co-expressing CFP-MLH1 + YFP-PMS2-775Ser had a four-fold increase in FRETc values (0.031 ± 0.013, n = 12; 0.008 ± 0.005, n = 12; *P*\< 0.001) (Figure [2A](#F2){ref-type="fig"}). This result suggested that the *PMS2*Ser775Asn polymorphism could significantly influence the interaction between MLH1 and PMS2.

![**FRET imaging of MLH1 and PMS2 interaction in live HEK293T cells**. Images of CFP-tagged (green) and YFP-tagged (red) constructs when transiently expressed in HEK293T cells. Co-localization of co-expressed constructs is shown as yellow in overlay images. The pseudocoloured images represent FRET signals corrected for any bleed-through using the micro-FRET method (FRETc). **A**: Co-localization (overlay) and direct interactions (FRETc) between MLH1-CFP + PMS2 (wt)-YFP were detected in the nucleus. **B**: Cells co-expressing MLH1-CFP + PMS2 S775N-YFP showed good co-localization of fluorescent signals but little detectable FRETc signal in the nucleus.](1741-7015-10-49-2){#F2}

We also used a co-immunoprecipitation assay to detect the effects of *PMS2*variants on the MLH1 and PMS2 interaction. Full-length MLH1 and PMS2 775Ser or PMS2 775Asn were constructed and co-transfected into HEK293T cells. Western blot analysis of whole cell lysates showed satisfied transfection efficiency (Figure [3A](#F3){ref-type="fig"}). The co-immunoprecipitated result also suggested that binding between MLH1 and PMS2-775Ser was more robust compared with binding between MLH1 and the PMS2-775Asn variant (Figure [3B](#F3){ref-type="fig"}, lane 4 vs. 3) which suggested that mutation of PMS2 significantly attenuated the protein-protein interaction of MLH1 and PMS2.

![**Interaction studies between hMLH1 and hPMS2 variants**. **A**: Western blot of total protein extracts (50 μg each) from HEK293T cells transfected with pcDNA3.1-MLH1 and either wild-type pcDNA3.1-PMS2 (775Ser) or pcDNA3.1-PMS2 (775Asn) variants. β-actin was used as controls. **B**: The lysates of cells co-expressing the two plasmid were immunoprecipitated with anti-MLH1 N-20 antibody, and then detected with anti-PMS2 (A16-4) antibody. Western blot signals were quantified employing Quantity-One software.](1741-7015-10-49-3){#F3}

Discussion
==========

Accumulating evidence demonstrates that MMR plays a critical role in the maintenance of genetic integrity and participates in the meiotic recombination process \[[@B14]-[@B16]\]. Although mutations in MMR genes are considered as potential risk factors for various cancers \[[@B28],[@B29]\], only limited data exist on the potential role of polymorphisms in the MMR genes on male infertility. To our knowledge, this study is the first to provide a comprehensive evaluation of the relationship between polymorphisms in MMR and susceptibility to male infertility in a relatively large sample size. On the basis of analysis of 480 controls and 524 infertility patients with azoospermia or oligozoospermia, we observed that one intronic SNP in *MLH1*(rs4647269) and two non-synonymous SNPs in *PMS2*(rs1059060, Ser775Asn) and *MSH5*(rs2075789, Pro29Ser) were associated with increased susceptibility to poor sperm production.

As an important pathway in the DNA damage repair network, MMR also plays a critical role in the maintenance of genetic integrity. Thus, it would be expected that these three significant SNPs that affect sperm DNA integrity could also modify male infertility risk. Based on a case-control study consisting of 480 controls and 768 patients with normal sperm count, we found that *PMS2*rs1059060 was significantly associated with male infertility with normal sperm count. Further analysis based on 450 infertile men revealed significant associations of *MLH1*rs4647269 and *PMS2*rs1059060 with sperm DNA fragmentation. However, we did not detect any association between *MSH5*Pro29Ser polymorphisms and sperm DNA damage. This result is explained by the fact that MSH5 is a meiosis-specific protein crucial for reciprocal recombination, and it has no apparent mismatch repair activity because it is missing the appropriate amino acid residues \[[@B30]\].

MLH1 and PMS2 form the MutLα heterodimer that leads to the repair of mismatched DNA through activation of exonuclease-mediated degradation of DNA \[[@B31]\]. Guerrette *et al.*localized the MLH1-PMS2 interaction region to amino acids 506-675 of MLH1 and amino acids 675-850 of PMS2 \[[@B32]\]. It is conceivable that the *PMS2*Ser775Asn polymorphism could directly impact the integrity of the interaction between MLH1 and PMS2. In the present study, we provided evidence, for the first time, that the *PMS2*Ser775Asn variant attenuates the interaction of MLH1 and PMS2, as illustrated by FRET and co-immunoprecipitation assays.

The *MSH5*rs2075789 polymorphism in the coding region of the human *MSH5*gene leads to a proline to serine alteration and is located within the MSH4-MSH5 interacting domain. To address the effect of the Pro29Ser alteration on the interaction between MSH4 and MSH5, a quantitative yeast two-hybrid analysis has been performed \[[@B33]\]. This alteration causes a moderate but significant reduction in the interactions between both proteins, which could affect the formation of the MSH4-MSH5 heterocomplex. These findings strongly support our molecular epidemiological observation that the MSH5 Pro29Ser polymorphism is associated with a significantly increased risk of azoospermia or oligozoospermia. Supporting evidence also comes from association studies by other investigators. In a recent study of a Chinese population with a small sample size, Xu *et al.*observed a 2.89-fold increased risk of azoospermia or oligozoospermia among the *MSH5*Pro29Ser allele carriers \[[@B34]\]. In addition, a case-control study including 41 women with premature ovarian failure and 39 controls suggested that there is a correlation between the MSH5 Pro29Ser polymorphism and premature ovarian failure in women \[[@B35]\].

Another SNP associated with risk in our study (rs4647269) is intronic. However, SNP rs4647269 tags SNP rs9852810 (r^2^= 1, *D*\' = 1), which was associated with prostate cancer risk and prostate cancer recurrence \[[@B36]\]. Because both of these two SNPs are located in the intron of the *MLH1*gene, it is uncertain which one of these two variants causes increases in male infertility risk. To identify additional SNPs that could be associated with male infertility risk that may be in high linkage disequilibrium (LD) with these two sites, we screened all of the common variants (with MAF \> 0.05) within an approximately 20 kb-long region surrounding these two sites (approximately 10 kb upstream and approximately 10 kb downstream of these loci) based on the CHB HapMap data resource. We found that rs4647269 is in complete LD with SNP rs1046512, which is located approximately 2.5 kb upstream of start codon of *MLH1*. Therefore, it is highly likely that the rs1046512 SNP near the 5\' region of the *MLH1*gene may be the causal variant.

Another interesting finding was that smoking was associated with increased risk of male infertility. Although the effects of tobacco cigarette smoke on male reproduction are somewhat inconclusive, a number of studies have shown higher incidences of abnormal sperm morphology \[[@B37],[@B38]\] and decreased sperm motility concentration in men who smoke \[[@B39],[@B40]\]. A meta-analysis \[[@B41]\], including 27 studies, indicated that cigarette smoking is associated with a 13% reduction in sperm concentration, a 10% reduction of sperm motility, and a 3% reduction of morphologically normal sperm. Furthermore, fluctuation in reproductive hormone levels have been documented in male smokers \[[@B42],[@B43]\]. However, the mechanism(s) of these changes, if any, remains unclear.

Of note, like all case-control studies, selection bias may exist and might influence interpretation of the results. However, we believe that potential confounding bias might have been minimized by matching the controls to the cases on age and by further adjustment for the confounding factors in statistical analyses. In addition, the fact that genotype frequencies of all SNPs in our controls fit Hardy-Weinberg equilibrium and were similar to those obtained from the HapMap Project further supports the randomness of our control selection. We believe that the selection bias, if any, is unlikely to be substantial.

Conclusions
===========

The present study extends the previous understanding of the MMR polymorphisms and their effects on the risk of idiopathic azoospermia or oligozoospermia by further evaluating the contribution of these polymorphisms in relation to sperm DNA fragmentation. These novel findings might be helpful in improving the understanding of the role of genetic variation in susceptibility to reduced sperm DNA integrity and in providing diagnostic implications for assisted reproduction success rates. Although, these three SNPs (rs4647269, rs1059060 and rs2075789) associated with risk in our study are significantly higher for some variants in the patient group, the actual rates are quite low and would potentially account for a low percentage of infertility. However, it is important to know that genetic variants associated with common complex diseases like male infertility are only \"one piece of the puzzle\" making up an individual\'s overall risk for disease. It is highly likely that the genetic risk for developing male infertility is influenced by the additive effects of many different genetic variants and other risk factors. So, further research is required to define their interactions with other susceptibility alleles and environmental factors can lead to a substantial increase in male infertility risk, especially when exposed to certain dietary and lifestyle habits.
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